Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1989-11-14
|
pubmed:abstractText |
We have investigated the structure and expression of the c-myc proto-oncogene in DNA isolated from the immortal cell line LNCaP. This cell line was derived from a lymph node metastasis of human prostate cancer. Msp I digest of LNCaP DNA when hybridized to a human c-myc probe showed a 1.45 kb band of intensity about two-fold greater than that observed in normal lymphocytes. In addition, the LNCaP cells contain rearranged and amplified c-myc structures which are not present in normal lymphocytes. Quantitation of these bands by scanning densitometry is consistent with an approximately 10-fold amplification of c-myc. To determine whether this amplification was accompanied by increased expression, RNA was isolated from these cells and compared to RNA isolated from a control cell line in which c-myc was not amplified. Northern blot analysis showed that the RNA transcripts from LNCaP cells were approximately 50-fold higher. Although androgens modulate the cell growth of LNCaP, there was no change in the level of c-myc RNA transcripts in serum-free medium in the presence or absence of androgens. Further investigation to determine whether altered structure, amplification, and overexpression of c-myc constitute a common characteristic of metastatic human prostate cancer might prove profitable in understanding this disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/HRAS protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-myc,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins p21(ras),
http://linkedlifedata.com/resource/pubmed/chemical/Testosterone
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0270-4137
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-22
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2678039-DNA, Neoplasm,
pubmed-meshheading:2678039-Gene Amplification,
pubmed-meshheading:2678039-Gene Expression,
pubmed-meshheading:2678039-Gene Rearrangement,
pubmed-meshheading:2678039-Humans,
pubmed-meshheading:2678039-Immunoblotting,
pubmed-meshheading:2678039-Male,
pubmed-meshheading:2678039-Mutation,
pubmed-meshheading:2678039-Oncogenes,
pubmed-meshheading:2678039-Prostatic Neoplasms,
pubmed-meshheading:2678039-Proto-Oncogene Proteins,
pubmed-meshheading:2678039-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:2678039-Proto-Oncogene Proteins p21(ras),
pubmed-meshheading:2678039-Proto-Oncogenes,
pubmed-meshheading:2678039-Testosterone,
pubmed-meshheading:2678039-Tumor Cells, Cultured
|
pubmed:year |
1989
|
pubmed:articleTitle |
Amplification, rearrangement, and elevated expression of c-myc in the human prostatic carcinoma cell line LNCaP.
|
pubmed:affiliation |
Scott Department of Urology, Baylor College of Medicine, Houston, Texas.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|